APACT: Phase III, multicenter, international, open-label, randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) versus gemcitabine (G) for surgically resected pancreatic adenocarcinoma Meeting Abstract


Authors: Ko, A.; Reni, M.; Riess, H.; Pelzer, U.; O'Reilly, E. M.; Winter, J.; Oh, D. Y.; Li, C. P.; Tortora, G.; Chang, H. M.; Lopez, C. D.; Tabernero, J.; Van Cutsem, E.; Philip, P.; Goldstein, D.; Berlin, J. D.; Ferrara, S.; Li, M.; Lu, B.; Romano, A.; Marks, H.; Biankin, A.; Tempero, M. A.
Abstract Title: APACT: Phase III, multicenter, international, open-label, randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) versus gemcitabine (G) for surgically resected pancreatic adenocarcinoma
Meeting Title: 50th Anniversary Joint Meeting of American Pancreatic Association (APA) and Japan Pancreas Society (JPS)
Journal Title: Pancreas
Volume: 48
Issue: 10
Meeting Dates: 2019 Nov 6-9
Meeting Location: Maui, HI
ISSN: 0885-3177
Publisher: Lippincott Williams & Wilkins  
Date Published: 2019-11-01
Start Page: 1464
Language: English
ACCESSION: WOS:000505712800276
PROVIDER: wos
DOI: 10.1097/MPA.0000000000001419
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Eileen O'Reilly
    421 O'Reilly